I-Mab (IMAB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

I-Mab currently has a Bullish sentiment score of 0.22.

About I-Mab

I-Mab is a leading clinical-stage biopharmaceutical company headquartered in Shanghai, China, specializing in the discovery and development of innovative biologics for cancer and autoimmune disorders. With a robust pipeline and strong research capabilities, I-Mab is dedicated to addressing significant unmet medical needs in both domestic and international markets. The company's strategic focus on cutting-edge therapies positions it as a key player in the biopharmaceutical sector, with the pot...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for I-Mab and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMAB pay dividends?

I-Mab (IMAB) does not currently pay a regular dividend.